{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:34:23Z","timestamp":1788986063061,"version":"build-2803163510"},"reference-count":70,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T00:00:00Z","timestamp":1694044800000},"content-version":"am","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Diseases Now"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.idnow.2022.05.003","type":"journal-article","created":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T11:43:04Z","timestamp":1651923784000},"page":"327-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Inhaled antibiotics in critical care: State of the art and future perspectives"],"prefix":"10.1016","volume":"52","author":[{"given":"Piotr","family":"Szychowiak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Desgrouas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ehrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idnow.2022.05.003_bib0355","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD 2022. https:\/\/goldcopd.org\/2022-gold-reports-2\/.(accessed 17 march 2022)."},{"key":"10.1016\/j.idnow.2022.05.003_bib0360","unstructured":"Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention 2021. https:\/\/ginasthma.org\/gina-reports\/(accessed 17 match 2022)."},{"key":"10.1016\/j.idnow.2022.05.003_bib0365","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s10096-017-3175-5","article-title":"Nebulization of antimicrobial agents in mechanically ventilated adults in 2017: an international cross-sectional survey","volume":"37","author":"Alves","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.idnow.2022.05.003_bib0370","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s00134-020-05980-0","article-title":"Ventilator-associated pneumonia in adults: a narrative review","volume":"46","author":"Papazian","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.idnow.2022.05.003_bib0375","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idnow.2022.05.003_bib0380","first-page":"332","article-title":"Microbial cause of ICU-acquired pneumonia: hospital-acquired pneumonia versus ventilator-associated pneumonia","volume":"24","author":"Luyt","year":"2018","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.idnow.2022.05.003_bib0385","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/MCP.0000000000000160","article-title":"Ventilator-associated infection: the role for inhaled antibiotics","volume":"21","author":"Palmer","year":"2015","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.idnow.2022.05.003_bib0390","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1089\/jamp.2020.29029.cd","article-title":"Deposition mechanisms","volume":"33","author":"Darquenne","year":"2020","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"10.1016\/j.idnow.2022.05.003_bib0395","first-page":"532","article-title":"Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution","volume":"60","author":"Rennard","year":"1986","journal-title":"J Appl Physiol Bethesda Md"},{"key":"10.1016\/j.idnow.2022.05.003_bib0400","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1164\/rccm.200204-363OC","article-title":"Lung deposition and efficiency of nebulized amikacin during Escherichia coli pneumonia in ventilated piglets","volume":"166","author":"Goldstein","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.idnow.2022.05.003_bib0405","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/00000542-200304000-00033","article-title":"Lack of lung tissue and systemic accumulation after consecutive daily aerosols of amikacin in ventilated piglets with healthy lungs","volume":"98","author":"Ferrari","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1016\/j.idnow.2022.05.003_bib0410","doi-asserted-by":"crossref","first-page":"R200","DOI":"10.1186\/cc8206","article-title":"Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia","volume":"13","author":"Luyt","year":"2009","journal-title":"Crit Care Lond Engl"},{"key":"10.1016\/j.idnow.2022.05.003_bib0415","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1473-3099(19)30574-2","article-title":"Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial","volume":"20","author":"Niederman","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idnow.2022.05.003_bib0420","doi-asserted-by":"crossref","first-page":"7331","DOI":"10.1128\/AAC.03510-14","article-title":"Comparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and colistin after aerosol delivery and intravenous administration of CMS in critically ill patients","volume":"58","author":"Boisson","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idnow.2022.05.003_bib0425","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1093\/jac\/dkw313","article-title":"Pharmacokinetics of high-dose nebulized amikacin in ventilated critically ill patients","volume":"71","author":"Petitcollin","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idnow.2022.05.003_bib0430","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s40262-015-0250-x","article-title":"Clinical pharmacokinetics of inhaled antimicrobials","volume":"54","author":"Stockmann","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.idnow.2022.05.003_bib0435","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1097\/ALN.0b013e3182755d7a","article-title":"Aerosolized antibiotics for ventilator-associated pneumonia: lessons from experimental studies","volume":"117","author":"Rouby","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1016\/j.idnow.2022.05.003_bib0440","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1097\/CCM.0b013e31817c0f9e","article-title":"Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit","volume":"36","author":"Palmer","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.idnow.2022.05.003_bib0445","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1164\/rccm.201011-1894OC","article-title":"Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa","volume":"184","author":"Lu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.idnow.2022.05.003_bib0450","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1164\/rccm.201312-2161OC","article-title":"Reduction of bacterial resistance with inhaled antibiotics in the intensive care unit","volume":"189","author":"Palmer","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.idnow.2022.05.003_bib0455","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.chest.2016.11.026","article-title":"A randomized trial of the amikacin fosfomycin inhalation system for the adjunctive therapy of gram-negative ventilator-associated pneumonia: IASIS trial","volume":"151","author":"Kollef","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.idnow.2022.05.003_bib0460","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1128\/AAC.01430-08","article-title":"Prevalence and risk factors for aminoglycoside nephrotoxicity in intensive care units","volume":"53","author":"Oliveira","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idnow.2022.05.003_bib0465","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/1471-2334-13-380","article-title":"Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study","volume":"13","author":"Sorl\u00ed","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.idnow.2022.05.003_bib0470","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13613-016-0127-7","article-title":"Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial","volume":"6","author":"Abdellatif","year":"2016","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.idnow.2022.05.003_bib0475","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/CCM.0000000000000771","article-title":"The role of aerosolized colistin in the treatment of ventilator-associated pneumonia: a systematic review and metaanalysis","volume":"43","author":"Valachis","year":"2015","journal-title":"Crit Care Med"},{"key":"10.1016\/j.idnow.2022.05.003_bib0480","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.ijantimicag.2015.09.011","article-title":"Intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of pneumonia caused by multidrug-resistant pathogens: a systematic review and meta-analysis","volume":"46","author":"Liu","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.idnow.2022.05.003_bib0485","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/ALN.0000000000001570","article-title":"Nebulization of antiinfective agents in invasively mechanically ventilated adults: a systematic review and meta-analysis","volume":"126","author":"Sol\u00e9-Lleonart","year":"2017","journal-title":"Anesthesiology"},{"key":"10.1016\/j.idnow.2022.05.003_bib0490","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s13054-018-2106-x","article-title":"Aerosolized antibiotics for ventilator-associated pneumonia: a pairwise and Bayesian network meta-analysis","volume":"22","author":"Xu","year":"2018","journal-title":"Crit Care Lond Engl"},{"key":"10.1016\/j.idnow.2022.05.003_bib0495","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s13054-017-1844-5","article-title":"Aerosol delivery during invasive mechanical ventilation: a systematic review","volume":"21","author":"Dugernier","year":"2017","journal-title":"Crit Care Lond Engl"},{"key":"10.1016\/j.idnow.2022.05.003_bib0500","first-page":"845","article-title":"Influence of nebulizer type, position, and bias flow on aerosol drug delivery in simulated pediatric and adult lung models during mechanical ventilation","volume":"55","author":"Ari","year":"2010","journal-title":"Respir Care"},{"key":"10.1016\/j.idnow.2022.05.003_bib0505","doi-asserted-by":"crossref","first-page":"00027","DOI":"10.1183\/23120541.00027-2021","article-title":"Delivered dose with jet and mesh nebulisers during spontaneous breathing, non-invasive ventilation and mechanical ventilation using adult lung models","volume":"7","author":"Ari","year":"2021","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.idnow.2022.05.003_bib0510","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1080\/10717544.2021.1951893","article-title":"An in vitro visual study of fugitive aerosols released during aerosol therapy to an invasively ventilated simulated patient","volume":"28","author":"Mac Giolla Eain","year":"2021","journal-title":"Drug Deliv"},{"key":"10.1016\/j.idnow.2022.05.003_bib0515","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13613-017-0301-6","article-title":"Nebulized antibiotics in mechanically ventilated patients: a challenge for translational research from technology to clinical care","volume":"7","author":"Ehrmann","year":"2017","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.idnow.2022.05.003_bib0520","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1365-2125.2003.01892.x","article-title":"Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications","volume":"56","author":"Labiris","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.idnow.2022.05.003_bib0525","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1164\/rccm.200210-1167OC","article-title":"Aerosol delivery and modern mechanical ventilation: in vitro\/in vivo evaluation","volume":"168","author":"Miller","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.idnow.2022.05.003_bib0530","first-page":"1336","article-title":"Influence of moisture accumulation in inline spacer on delivery of aerosol using metered-dose inhaler during mechanical ventilation","volume":"54","author":"Lin","year":"2009","journal-title":"Respir Care"},{"key":"10.1016\/j.idnow.2022.05.003_bib0535","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/QCO.0000000000000633","article-title":"Optimizing aerosol delivery of antibiotics in ventilated patients","volume":"33","author":"Ehrmann","year":"2020","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.idnow.2022.05.003_bib0540","doi-asserted-by":"crossref","DOI":"10.1089\/jamp.2020.1623","article-title":"The effect of different interfaces on the aerosol delivery with vibrating Mesh nebulizer during non-invasive positive pressure ventilation","author":"Tan","year":"2021","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"10.1016\/j.idnow.2022.05.003_bib0545","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S1473-3099(20)30481-3","article-title":"The INHALE trial: multiple reasons for a negative result","volume":"20","author":"Rouby","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idnow.2022.05.003_bib0550","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S2213-2600(15)00326-4","article-title":"Incidence and prognosis of ventilator-associated tracheobronchitis (TAVeM): a multicentre, prospective, observational study","volume":"3","author":"Martin-Loeches","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.idnow.2022.05.003_bib0555","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ijantimicag.2017.01.013","article-title":"Non-inferiority of colistin compared with standard care for the treatment of ventilator-associated pneumonia","volume":"49","author":"Tulli","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.idnow.2022.05.003_bib0560","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13054-015-0868-y","article-title":"Nebulized antibiotics for ventilator-associated pneumonia: a systematic review and meta-analysis","volume":"19","author":"Zampieri","year":"2015","journal-title":"Crit Care Lond Engl"},{"key":"10.1016\/j.idnow.2022.05.003_bib0565","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1592\/phco.22.12.972.33596","article-title":"Aerosolized ceftazidime for prevention of ventilator-associated pneumonia and drug effects on the proinflammatory response in critically ill trauma patients","volume":"22","author":"Wood","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.idnow.2022.05.003_bib0570","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1183\/13993003.02235-2014","article-title":"Nebulised colistin for ventilator-associated pneumonia prevention","volume":"46","author":"Karvouniaris","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.idnow.2022.05.003_bib0575","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jcrc.2017.09.019","article-title":"Effect of antibiotics administered via the respiratory tract in the prevention of ventilator-associated pneumonia: a systematic review and meta-analysis","volume":"43","author":"P\u00f3voa","year":"2018","journal-title":"J Crit Care"},{"key":"10.1016\/j.idnow.2022.05.003_bib0580","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/sur.2006.042","article-title":"Aerosolized ceftazidime prophylaxis against ventilator-associated pneumonia in high-risk trauma patients: results of a double-blind randomized study","volume":"8","author":"Claridge","year":"2007","journal-title":"Surg Infect"},{"key":"10.1016\/j.idnow.2022.05.003_bib0585","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00134-015-4114-5","article-title":"Aerosol therapy in intensive and intermediate care units: prospective observation of 2808 critically ill patients","volume":"42","author":"Ehrmann","year":"2016","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.idnow.2022.05.003_bib0590","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1007\/s00134-013-2872-5","article-title":"Aerosol therapy during mechanical ventilation: an international survey","volume":"39","author":"Ehrmann","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.idnow.2022.05.003_bib0595","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/jamp.2018.1484","article-title":"Salbutamol nebulization during non-invasive ventilation in exacerbated chronic obstructive pulmonary disease patients: a randomized controlled trial","volume":"32","author":"Bodet-Contentin","year":"2019","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"10.1016\/j.idnow.2022.05.003_bib0600","doi-asserted-by":"crossref","first-page":"590","DOI":"10.21037\/atm-20-7383","article-title":"Narrative review of practical aspects of aerosol delivery via high-flow nasal cannula","volume":"9","author":"Li","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.idnow.2022.05.003_bib0605","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.4187\/respcare.08996","article-title":"Worldwide clinical practice of high-flow nasal cannula and concomitant aerosol therapy in the adult ICU setting","volume":"66","author":"Li","year":"2021","journal-title":"Respir Care"},{"key":"10.1016\/j.idnow.2022.05.003_bib0610","doi-asserted-by":"crossref","first-page":"737","DOI":"10.4187\/respcare.04748","article-title":"Should aerosolized antibiotics be used to treat ventilator-associated pneumonia?","volume":"61","author":"Zhang","year":"2016","journal-title":"Respir Care"},{"key":"10.1016\/j.idnow.2022.05.003_bib0615","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s40265-017-0787-0","article-title":"Inhaled antimicrobials for ventilator-associated pneumonia: practical aspects","volume":"77","author":"Poulakou","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.idnow.2022.05.003_bib0620","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.ccm.2018.08.005","article-title":"Aerosol therapy for pneumonia in the intensive care unit","volume":"39","author":"Luyt","year":"2018","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.idnow.2022.05.003_bib0625","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1093\/jac\/dkq360","article-title":"Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria","volume":"65","author":"Rattanaumpawan","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idnow.2022.05.003_bib0630","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13613-016-0140-x","article-title":"Characteristics of an ideal nebulized antibiotic for the treatment of pneumonia in the intubated patient","volume":"6","author":"Bassetti","year":"2016","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.idnow.2022.05.003_bib0635","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.idnow.2022.05.003_bib0640","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with COVID-19","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.idnow.2022.05.003_bib0645","article-title":"Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis","author":"Shankar-Hari","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.idnow.2022.05.003_bib0650","doi-asserted-by":"crossref","DOI":"10.1007\/s00134-020-06323-9","article-title":"Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study","author":"Rouz\u00e9","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.idnow.2022.05.003_bib0655","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cmi.2017.04.011","article-title":"Use of nebulized antimicrobials for the treatment of respiratory infections in invasively mechanically ventilated adults: a position paper from the European Society of Clinical Microbiology and Infectious Diseases","volume":"23","author":"Rello","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.idnow.2022.05.003_bib0660","doi-asserted-by":"crossref","first-page":"101807","DOI":"10.1016\/j.pupt.2019.101807","article-title":"Intra-tracheal amikacin spray delivery in healthy mechanically ventilated piglets","volume":"57","author":"Guillon","year":"2019","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.idnow.2022.05.003_bib0665","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/17425247.2018.1503251","article-title":"Designing inhaled protein therapeutics for topical lung delivery: what are the next steps?","volume":"15","author":"Bodier-Montagutelli","year":"2018","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.idnow.2022.05.003_bib0670","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1080\/17425247.2017.1252329","article-title":"Inhaled phage therapy: a promising and challenging approach to treat bacterial respiratory infections","volume":"14","author":"Bodier-Montagutelli","year":"2017","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.idnow.2022.05.003_bib0675","doi-asserted-by":"crossref","DOI":"10.1111\/bph.15526","article-title":"Inhaled bacteriophage therapy in a porcine model of pneumonia caused by Pseudomonas aeruginosa during mechanical ventilation","author":"Guillon","year":"2021","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.idnow.2022.05.003_bib0680","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1089\/phage.2020.0014","article-title":"Bacteriophages could be a potential game changer in the trajectory of coronavirus disease (COVID-19)","volume":"1","author":"Wojewodzic","year":"2020","journal-title":"Phage"},{"key":"10.1016\/j.idnow.2022.05.003_bib0685","doi-asserted-by":"crossref","first-page":"e73396","DOI":"10.1371\/journal.pone.0073396","article-title":"The anti-Pseudomonas aeruginosa antibody Panobacumab is efficacious on acute pneumonia in neutropenic mice and has additive effects with meropenem","volume":"8","author":"Secher","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.idnow.2022.05.003_bib0690","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1080\/19420862.2016.1196521","article-title":"Therapeutic monoclonal antibodies for respiratory diseases: current challenges and perspectives, March 31st\u2013April 1st, 2016, Tours, France","volume":"8","author":"Desoubeaux","year":"2016","journal-title":"MAbs"},{"key":"10.1016\/j.idnow.2022.05.003_bib0695","doi-asserted-by":"crossref","DOI":"10.1165\/rcmb.2021-0125OC","article-title":"Airway administration of flagellin regulates the inflammatory response to pseudomonas aeruginosa","author":"L\u00f3pez-G\u00e1lvez","year":"2021","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.idnow.2022.05.003_bib0700","doi-asserted-by":"crossref","first-page":"e0236216","DOI":"10.1371\/journal.pone.0236216","article-title":"The Toll-Like Receptor 5 agonist flagellin prevents non-typeable haemophilus influenzae-induced infection in cigarette smoke-exposed mice","volume":"16","author":"P\u00e9rez-Cruz","year":"2021","journal-title":"PloS One"}],"container-title":["Infectious Diseases Now"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991922000926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991922000926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:32:22Z","timestamp":1763019142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666991922000926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":70,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S2666991922000926"],"URL":"https:\/\/doi.org\/10.1016\/j.idnow.2022.05.003","relation":{},"ISSN":["2666-9919"],"issn-type":[{"value":"2666-9919","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhaled antibiotics in critical care: State of the art and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Infectious Diseases Now","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idnow.2022.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}